Skip to main content
. 2016 Jan 4;11(3):431–441. doi: 10.2215/CJN.06290615

Table 4.

Causes of death in patients with monoclonal gammopathy and control patients on chronic dialysis

Causes of Death ALA (n=173) LCDD (n=218) MCN (n=591) P Value Patients with MG (n=982) Controls on Dialysis (n=2171) P Value
Cardiovascular disease (%) 53 (30.6) 33 (15.1) 91 (15.4) <0.001 177 (18) 773 (35.6) <0.001
 Sudden cardiac death 20 (11.6) 12 (5.5) 42 (7.1) 74 (7.5) 239 (11)
 Cerebrovascular disease 7 (4) 7 (3.2) 17 (2.9) 31 (3.2) 98 (4.5)
 Congestive heart failure 12 (6.9) 4 (1.8) 10 (1.7) 26 (2.6) 128 (5.9)
 Myocardial infarction 4 (2.3) 3 (1.4) 8 (1.4) 15 (1.5) 122 (5.6)
 Cardiac arrhythmia 3 (1.7) 3 (1.4) 4 (0.7) 10 (1) 41 (1.9)
 Pulmonary embolism 0 1 (0.5) 1 (0.2) 2 (0.2) 12 (0.6)
 Others 7 (4) 3 (1.4) 9 (1.5) 19 (1.9) 133 (6.1)
Infectious disease (%) 20 (11.6) 33 (15.1) 78 (13.2) 0.58 131 (13.3) 247 (11.4) 0.11
 Septicemia 15 (8.7) 17 (7.8) 41 (6.9) 73 (7.4) 146 (6.7)
 Pulmonary infection 2 (1.2) 8 (3.7) 22 (3.7) 32 (3.3) 56 (2.6)
 Peritonitis 0 2 (0.9) 4 (0.7) 6 (0.6) 12 (0.6)
 Others 3 (1.7) 6 (2.8) 11 (1.9) 20 (2) 33 (1.5)
Malignancy (%) 21 (12.1) 71 (32.6) 246 (41.6) <0.001 338 (34.4) 188 (8.7) <0.001
 Solid malignancy 20 (11.6) 50 (22.9) 105 (17.8) 175 (17.8) 180 (8.3)
 Hematologic disease 1 (0.6) 21 (9.6) 141 (23.9) 163 (16.6) 8 (0.4)
Others (%)
 Cachexia 15 (8.7) 7 (3.2) 29 (4.9) 0.05 51 (5.2) 144 (6.6) 0.12
 All-causes bleedings 1 (0.6) 4 (1.8) 7 (1.2) 0.05 12 (1.2) 44 (2) 0.11
 Hyperkaliemia 0 2 (0.9) 5 (0.8) 0.65 7 (0.7) 17 (0.8) 0.83
 Others known causes 29 (16.8) 21 (9.6) 56 (9.5) 0.02 106 (10.8) 295 (13.6) 0.03
 Unknown causes 34 (19.7) 47 (21.6) 79 (13.4) <0.01 160 (16.3) 462 (21.3) 0.001

ALA, immunoglobulin light chain amyloidosis; LCDD, light–chain deposition disease; MCN, myeloma cast nephropathy; MG, monoclonal gammopathy.